Skip to main content
. 2022 Jan 11;11:757073. doi: 10.3389/fonc.2021.757073

Figure 3.

Figure 3

Receiver operating characteristics (ROC) curves for examined immunoresolvents as potential (bio)markers of pancreatic cancer. Calculated sensitivity (y-axis) is plotted against 1-specificity formula (x-axis) for examined immunoresolvents: (A) lipoxin A4 (LPxA4), (B) lipoxin B4 (LPxB4), (C) resolvin D1 (RsvD1) and (D) resolvin D2 (RsvD2) as potential indicators of pancreatic cancer. AUC, area under ROC curve; p, level of significance.